A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell...
Immunoproliferative Disorders. Immune System Diseases. Lymphoma, Non-Hodgkin. Leukemia, Lymphoid. Leukemia. Leukemia, B-Cell. ... University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008. Recruiting. ... classification of neoplasms of the hematopoietic and lymphoid tissues and has relapsed or refractory disease after at least 2 ... classification of neoplasms of the hematopoietic and lymphoid tissues and has relapsed or refractory disease after at least 1 ...
Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP...
Lymphoproliferative Disorders. Lymphatic Diseases. Immunoproliferative Disorders. Immune System Diseases. Lymphoma, Non-Hodgkin ... Any other histological type of lymphoma according to World Health Organization (WHO) 2016 classification of lymphoid neoplasms ...